Spyre Therapeutics (SYRE) Files Mixed Shelf
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/28/2026
- S&P 500 ends lower; chips tumble and Moderna rallies
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
Form S-3 Spyre Therapeutics, Inc.
September 6, 2024 4:07 PM EDTAs filed with the Securities and Exchange Commission on September 6, 2024. Registration No. 333-... More
